How the pharma industry can tackle the shortage of QPs by Lynne Byers, Senior Director Pharma Consulting, NSF Health Sciences.
List view / Grid view
Whitepapers & App Notes
Modern technology for signal detection and signal management in PV is pivotal to ensure the patient’s safety.
Single use technologies is highly booming in biopharmaceutical sector due to its efficient use and benefits.
PCI’s Tim Roberts discusses key factors when outsourcing the clinical and commercial supply of biologics, and what makes a strong CDMO partnership.
Find out how a pharma company maintained product quality and reduced plate counts by 25 percent using a rapid microbial monitoring analyser – the 7000RMS.
The importance of thoroughly planned resupply strategies in maintaining clinical supply inventories as studies move into late phase.
The demand for biologics and high potent medicines is forcing the industry to consider alternatives, such as outsourcing and integrated solutions.
Learn strategies to improve supply chain efficiency, reduce risk and respond to local, regional and global challenges.
Learn the benefits of collaboration between the pharmaceutical scientists and clinical supply services teams.
Learn about 21CFR.11 and Annex 11 requirements and how you can implement a rapid bioburden analyser designed to meet compliant operation needs.
Best practices for leveraging the resources of sourcing vendors are vital to anticipating and avoiding clinical supply delays.
Could ELGA’s PURELAB® Pharma Compliance reliable, intuitive and simple to use GMP ready system be the future for your ultrapure water needs?
Discover why Merck’s new MAS-100 Atmos® compressed gas sampler should be your go to for detecting microbial contamination…
How to select a CDMO partner for the development and commercial manufacture, packaging and launch of products containing highly potent APIs.
Water content determination of Ibuprofen tablets with an automated Karl Fischer titrator coupling with gas phase extraction.